Janus Henderson Group: CVS Health CVS Historial de posiciones en acciones
Comprado
Mantenidas
Vendido
| Trimestre | Valor de mercado | Estado | Acciones |
Cambio en la posición | Valor operado | Peso en el portafolio | Puesto en el portafolio | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | USD 680 M | Compra |
7,936,506
+4,258,682
| +116% | +USD 417 M | 0.29% | 76 |
|
|
2026
Q2 | USD 380 M | Compra |
3,677,824
+140,963
| +4% | +USD 12.6 M | 0.16% | 139 |
|
|
2026
Q1 | USD 254 M | Venta |
3,536,861
-80,085
| -2% | -USD 6.17 M | 0.12% | 167 |
|
|
2025
Q4 | USD 287 M | Compra |
3,616,946
+246,471
| +7% | +USD 19.4 M | 0.13% | 159 |
|
|
2025
Q3 | USD 254 M | Compra |
3,370,475
+354,812
| +12% | +USD 24.3 M | 0.12% | 164 |
|
|
2025
Q2 | USD 208 M | Compra |
3,015,663
+915,337
| +44% | +USD 60 M | 0.1% | 184 |
|
|
2025
Q1 | USD 141 M | Compra |
2,100,326
+1,335,140
| +174% | +USD 79.9 M | 0.08% | 218 |
|
|
2024
Q4 | USD 34.4 M | Compra |
765,186
+4,283
| +0.6% | +USD 240 k | 0.02% | 468 |
|
|
2024
Q3 | USD 47.8 M | Compra |
760,903
+599,200
| +371% | +USD 35 M | 0.02% | 397 |
|
|
2024
Q2 | USD 9.6 M | Venta |
161,703
-15,669
| -9% | -USD 980 k | 0.01% | 678 |
|
|
2024
Q1 | USD 14.1 M | Compra |
177,372
+4,318
| +2% | +USD 330 k | 0.01% | 623 |
|
|
2023
Q4 | USD 13.7 M | Venta |
173,054
-4,861
| -3% | -USD 346 k | 0.01% | 613 |
|
|
2023
Q3 | USD 12.4 M | Venta |
177,915
-42,430
| -19% | -USD 3.01 M | 0.01% | 624 |
|
|
2023
Q2 | USD 15.2 M | Compra |
220,345
+20,891
| +10% | +USD 1.49 M | 0.01% | 604 |
|
|
2023
Q1 | USD 14.8 M | Compra |
199,454
+2,302
| +1% | +USD 193 k | 0.01% | 633 |
|
|
2022
Q4 | USD 18.4 M | Compra |
197,152
+38,835
| +25% | +USD 3.75 M | 0.01% | 586 |
|
|
2022
Q3 | USD 15.1 M | Venta |
158,317
-12,324
| -7% | -USD 1.22 M | 0.01% | 603 |
|
|
2022
Q2 | USD 15.8 M | Venta |
170,641
-2,526,222
| -94% | -USD 247 M | 0.01% | 606 |
|
|
2022
Q1 | USD 273 M | Venta |
2,696,863
-548,607
| -17% | -USD 57.6 M | 0.13% | 173 |
|
|
2021
Q4 | USD 335 M | Venta |
3,245,470
-1,091,387
| -25% | -USD 101 M | 0.14% | 166 |
|
|
2021
Q3 | USD 368 M | Venta |
4,336,857
-446,598
| -9% | -USD 37.4 M | 0.16% | 147 |
|
|
2021
Q2 | USD 399 M | Compra |
4,783,455
+31,362
| +0.7% | +USD 2.57 M | 0.17% | 139 |
|
|
2021
Q1 | USD 357 M | Compra |
4,752,093
+1,124,402
| +31% | +USD 81.9 M | 0.16% | 149 |
|
|
2020
Q4 | USD 248 M | Compra |
3,627,691
+355,650
| +11% | +USD 23.1 M | 0.12% | 190 |
|
|
2020
Q3 | USD 191 M | Compra |
3,272,041
+1,256,506
| +62% | +USD 78.2 M | 0.1% | 212 |
|
|
2020
Q2 | USD 131 M | Compra |
2,015,535
+11,354
| +0.6% | +USD 715 k | 0.07% | 262 |
|
|
2020
Q1 | USD 119 M | Compra |
2,004,181
+811,572
| +68% | +USD 54.2 M | 0.08% | 251 |
|
|
2019
Q4 | USD 88.6 M | Compra |
1,192,609
+609,100
| +104% | +USD 42.8 M | 0.05% | 414 |
|
|
2019
Q3 | USD 36.8 M | Venta |
583,509
-27,905
| -5% | -USD 1.65 M | 0.02% | 670 |
|
|
2019
Q2 | USD 33.3 M | Venta |
611,414
-481,399
| -44% | -USD 25.9 M | 0.02% | 683 |
|
|
2019
Q1 | USD 58.9 M | Venta |
1,092,813
-513,344
| -32% | -USD 31.7 M | 0.03% | 541 |
|
|
2018
Q4 | USD 105 M | Compra |
1,606,157
+434,262
| +37% | +USD 32.4 M | 0.07% | 333 |
|
|
2018
Q3 | USD 92.3 M | Compra |
1,171,895
+555,880
| +90% | +USD 39.7 M | 0.05% | 419 |
|
|
2018
Q2 | USD 39.6 M | Venta |
616,015
-2,283
| -0.4% | -USD 150 k | 0.02% | 619 |
|
|
2018
Q1 | USD 38.5 M | Venta |
618,298
-246,615
| -29% | -USD 17.7 M | 0.02% | 620 |
|
|
2017
Q4 | USD 62.7 M | Venta |
864,913
-26,524
| -3% | -USD 1.93 M | 0.04% | 485 |
|
|
2017
Q3 | USD 72.5 M | Compra |
891,437
+159,671
| +22% | +USD 12.6 M | 0.05% | 434 |
|
|
2017
Q2 | USD 58.9 M | Sin cambios |
731,766
| – | – | 0.04% | 475 |
|
|
2017
Q1 | USD 45 M | Compra |
572,758
+36,842
| +7% | +USD 2.94 M | 0.32% | 78 |
|
|
2016
Q4 | USD 42.3 M | Venta |
535,916
-439,289
| -45% | -USD 35.5 M | 0.31% | 80 |
|
|
2016
Q3 | USD 86.8 M | Compra |
975,205
+17,254
| +2% | +USD 1.63 M | 0.64% | 25 |
|
|
2016
Q2 | USD 91.7 M | Compra |
957,951
+30,279
| +3% | +USD 3.02 M | 0.76% | 19 |
|
|
2016
Q1 | USD 96.2 M | Compra |
927,672
+37,172
| +4% | +USD 3.61 M | 0.78% | 16 |
|
|
2015
Q4 | USD 87 M | Venta |
890,500
-71,277
| -7% | -USD 6.98 M | 0.7% | 20 |
|
|
2015
Q3 | USD 92.8 M | Compra |
961,777
+271,110
| +39% | +USD 28.5 M | 0.82% | 16 |
|
|
2015
Q2 | USD 72.4 M | Venta |
690,667
-6,550
| -0.9% | -USD 669 k | 0.57% | 29 |
|
|
2015
Q1 | USD 72 M | Venta |
697,217
-40,508
| -5% | -USD 4.1 M | 0.56% | 29 |
|
|
2014
Q4 | USD 71.1 M | Compra |
737,725
+17,402
| +2% | +USD 1.53 M | 0.51% | 37 |
|
|
2014
Q3 | USD 57.3 M | Compra |
720,323
+234,467
| +48% | +USD 18.5 M | 0.54% | 45 |
|
|
2014
Q2 | USD 36.6 M | Venta |
485,856
-65,761
| -12% | -USD 4.97 M | 0.34% | 69 |
|
|
2014
Q1 | USD 41.3 M | Compra |
551,617
+140,599
| +34% | +USD 9.9 M | 0.4% | 59 |
|
|
2013
Q4 | USD 29.4 M | Compra |
411,018
+2,843
| +0.7% | +USD 183 k | 0.3% | 84 |
|
|
2013
Q3 | USD 23.2 M | Compra |
408,175
+30,084
| +8% | +USD 1.79 M | 0.26% | 102 |
|
|
2013
Q2 | USD 21.8 M | Sin cambios |
378,091
| – | – | 0.25% | 107 |
|
Otros fondos que tienen CVS en su portafolio
Posición de Janus Henderson Group en CVS: resumen de T3 2026
Janus Henderson Group aumentó su participación en CVS Health (CVS) en 116% durante T3 2026, al comprar aproximadamente USD 417 M y elevar la posición a 7,936,506 acciones con un valor de USD 680 M. La posición representa 0.29% del portafolio y ocupa el puesto #76.
Janus Henderson Group reportó por primera vez una posición en CVS en T2 2013 y desde entonces la ha mantenido en 54 trimestres. Al cierre de T3 2026, 1,994 fondos que sigue Wall St. Rank mantienen una posición en CVS.
- Al cierre de T3 2026, Janus Henderson Group tenía 7,936,506 acciones de CVS Health con un valor de USD 680 M.
- Janus Henderson Group compró 4,258,682 acciones de CVS Health en T3 2026, por un monto estimado de USD 417 M.
- CVS Health representó el 0.29% del portafolio de Janus Henderson Group en T3 2026 y fue su posición número 76.
- Janus Henderson Group reportó por primera vez una posición en CVS Health en T2 2013 y desde entonces la ha mantenido en 54 trimestres.
- Al cierre de T3 2026, 1,994 fondos que sigue Wall St. Rank tenían CVS Health en su portafolio.
Según el informe 13F de Janus Henderson Group correspondiente a T3 2026, presentado el 16 nov 2026.